↓ Skip to main content

Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s Disease

Overview of attention for article published in Frontiers in Pharmacology, October 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
twitter
5 X users

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s Disease
Published in
Frontiers in Pharmacology, October 2019
DOI 10.3389/fphar.2019.01294
Pubmed ID
Authors

Ane Murueta-Goyena, Ane Andikoetxea, Juan Carlos Gómez-Esteban, Iñigo Gabilondo

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 64 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 12 19%
Student > Master 7 11%
Student > Bachelor 7 11%
Professor 4 6%
Researcher 4 6%
Other 10 16%
Unknown 20 31%
Readers by discipline Count As %
Neuroscience 12 19%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Immunology and Microbiology 5 8%
Biochemistry, Genetics and Molecular Biology 4 6%
Nursing and Health Professions 4 6%
Other 10 16%
Unknown 24 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 November 2019.
All research outputs
#2,758,296
of 23,170,347 outputs
Outputs from Frontiers in Pharmacology
#1,082
of 16,566 outputs
Outputs of similar age
#60,205
of 362,973 outputs
Outputs of similar age from Frontiers in Pharmacology
#45
of 437 outputs
Altmetric has tracked 23,170,347 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,566 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,973 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 437 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.